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Research
known about contraceptive 
agement by GPs, what occurs
ing a contraceptive consult
and how this affects contrace
use and reproductive health
comes. Therefore, our aim in
study was to determine cu2) · 16 July 2012Objective:  To determine current contraceptive management by general 
practitioners in Australia.
Design, setting and participants:  Analysis of data from a random sample of 
3910 Australian GPs who participated in the Bettering the Evaluation and Care 
of Health (BEACH) survey, a continuous cross-sectional survey of GP activity, 
between April 2007 and March 2011. Consultations with female patients aged 
12–54 years that involved all forms of contraception were analysed.
Main outcome measures:  GP and patient characteristics associated with the 
management of contraception; types of contraception used; rates of encounters 
involving emergency contraception.
Results:  Increased age, ethnicity, Indigenous status and holding a 
Commonwealth Health Care Card were significantly associated with low rates of 
encounters involving management of contraception. The combined oral 
contraceptive pill was the most frequently prescribed method of contraception, 
with moderate prescription of long-acting reversible contraception (LARC), 
especially among women aged 34–54 years. Rates of consultations concerned 
with emergency contraception were low, but involved high rates of counselling, 
advice or education (48%) compared with encounters for general 
contraception (> 20%).
Conclusion:  A shift towards prescribing LARC, as recommended in clinical 
guidelines, has yet to occur in Australian general practice. Better understanding 






D,1 pite nearly 70% of Aus-lian women of reproduc-e age using a contraceptive
 estimates are that over
50% of Australian women have had
an unplanned pregnancy.2 This rate,
similar to that in the United King-
dom (30%)3 and United States
(49%),4 may in part be explained by
the fact that the combined oral con-
traceptive pill (COCP) remains the
preferred method of contraception
in Australia1,5,6 as it is in the UK3
and US.7
Clinical guidelines recommend
increased availability and accessibil-
ity of emergency contraception and
promotion of long-acting reversible
contraception (LARC; eg, intrauter-
ine devices and contraceptive
implants).3,8 Emergency contracep-
tion has been available over-the-
counter in Australia since 20049 but
this has had little effect on the actual
use of emergency contraception.10
Most Australian women remain
unaware of the over-the-counter
availability of emergency contracep-
tion, have misconceptions about it,
and want more information from
their general practitioners.9,11
The uptake of LARC is also low in
Australia, with only 1.2% of women
using it.1 Benefits of LARC include
minimal maintenance once in place,
and long-term, effective contracep-
tion. Increasing access to LARC is a
public health priority in the UK3 and
US,8 but there is no clear policy on
LARC in Australia.
While contraception and repro-
ductive health are core aspects of








management of contraceptive issues
by GPs in Australia.
Methods
We analysed data from the Bettering
the Evaluation and Care of Health
(BEACH) program, collected from
April 2007 to March 2011. BEACH is a
continuous, paper-based, national
study of GP activity in Australia.12
Each year, a national, rolling random
sample of 1000 GPs each provides
information for 100 consecutive con-
sultations with consenting, unidenti-
fied patients. The University of
Sydney Human Research Ethics
Committee and the Australian Insti-
tute of Health and Welfare Ethics
Committee have approved BEACH.
We restricted our analysis to
encounters between GPs and female
patients of reproductive age (defined
as 12–54 years of age) and examined
GP and patient characteristics, and up
to four problems managed per con-
sultation. For each problem, manage-
ment data include medications,
cl inical  treatments,  procedures
undertaken, pathology orders, and
referrals. Problems managed at con-
sultations were classified according to
the International classification of pri-
mary care, 2nd edition (ICPC-2)13 and
coded to more specific ICPC-2 PLUS
terminology.14 General contraception
was defined as including “Oral con-
traception” (ICPC-2 code W11),
“Intrauterine contraception” (W12),
“Female sterilisation” (W13), “Other
female contraception” (W14) and
“Reproductive medication” (W50).
Emergency contraception was defined
as “Post-coital contraception” (W10),
“Fear of pregnancy” (W02) and
“Unprotected sex, Female” (A23011).
The BEACH study uses a single-
stage cluster design, with a cluster of
consultations around each GP. In all
analyses, we adjusted for this cluster
using survey procedures in SAS statis-
tical software (SAS Institute Inc, Cary,
NC, USA). Statistical significance of
differences was determined by non-
overlapping 95% CIs.
Results
From April 2007 to March 2011, 3910
GPs participated in BEACH, recording
391 000 patient encounters. Of these,
Research114 034 (29.2%) were with females
aged 12–54 years: 7616 (6.7%) with
12–17-year-olds, 17 405 (15.3%) with
18–24-year-olds, 27 920 (24.5%) with
25–34-year-olds, 29 206 (25.6%) with
35–44-year-olds and 31 887 (28.0%)
with 45–54-year-olds.
Contraceptive problems (general or
emergency) were managed at a rate of
6.1 per 100 consultations (95% CI,
5.9–6.3). Women aged 18–24 years
had the highest rate of management
for general contraception, and this
rate decreased with age. Similar
trends were observed for emergency
contraception management.
Female patients who were Indige-
nous, spoke a language other than
English at home, held a Common-
wealth Health Care Card or had been
to the general practice before had sig-
nificantly lower general contraceptive
management rates (Box 1). Only one
of the patient characteristics had a
significant influence on emergency
contraception man agement —
patients new to the practice were
three times more likely than patients
known to the practice to have emer-
gency contraception managed (Box 1).
Female GPs managed general con-
traception more frequently than their
male counterparts. GPs aged less
than 35 years managed general con-
traception most often and those aged
55 years and older least often. GPs
who held a Fellowship from the
Royal Australian College of General
Practitioners (RACGP) had higher
rates of management of general con-
traception. GPs in solo practice man-
aged general contraception less often
than those working in larger prac-
tices (Box 2).
Medication was the most common
form of general contraception, being
prescribed, supplied, or recom-
mended for over-the-counter pur-
chase 90 times per 100 contraception
problems managed. Most of the
medications recorded were COCPs
with combined levonorgestrel/ethinyl-
oestradiol being the most frequently
recorded individual medication,
accounting for nearly half the medica-
tions for all age groups (Box 3). Dros-
p i ren o ne /e th iny lest ra d io l  an d
cyproterone/ethinyloestradiol (also
COCPs) were more f requently
recorded for 12–34-year-olds than
those aged 35–54 years. The reverse
was true for LARCs, with medroxy-
progesterone and the levonorgestrel
intrauterine device being recorded
more often for 35–54-year-olds than
for 12–34-year-olds. Copper intra-
uterine and ethinyloestradiol/eto-
nogestrel devices were least often
prescribed. For emergency contracep-
tion problems, levonorgestrel was the
most frequently recorded medication.
Clinical treatments (primarily
counselling, advice and education)
were the next most common form of
management, used at twice the rate in
1 Rate of contraceptive management at 114 034 consultations with women aged 12–54 years according to patient 
characteristics
Rate per 1000 consultations (95% CI)
Patient characteristic General contraception Emergency contraception Total contraception
New to practice (missing data for 1218 consultations*)
Yes 75.26 (69.34–81.18) 3.03 (1.86–4.19) 78.29 (72.23–84.35)
No 58.5  (56.68–60.33) 0.90 (0.71–1.10) 59.41 (57.57–61.25)
Non-English speaking background? (missing data for 12 678 consultations*)
Yes 34.02 (29.44–38.61) 1.37 (0.54–2.21) 35.39 (30.72–40.08)
No 62.60 (60.60–64.59) 1.06 (0.84–1.28) 63.65 (61.63–65.67)
Commonwealth Health Care Card? (missing data for 10 204 consultations*)
Yes 50.34 (47.46–53.21) 1.18 (0.76–1.60) 51.51 (48.60–54.43)
No 63.58 (61.36–65.79) 1.08 (0.83–1.32) 64.65 (62.41–66.89)
Indigenous? (missing data for 12 664 consultations*)
Yes 43.80 (31.75–55.84) 1.04 (0.00–2.46) 44.83 (32.48–57.19)
No 60.43 (58.51–62.35) 1.10 (0.88–1.31) 61.52 (59.58–63.47)
State (missing data for 2199 consultations*)
Australian Capital Territory 70.24 (56.35–84.13) 1.66 (0.00–3.57) 71.90 (57.03–0.87)
New South Wales 54.48 (51.52–57.44) 0.94 (0.63–1.25) 55.42 (52.43–58.40)
Victoria 57.38 (53.86–60.90) 1.07 (0.66–1.49) 58.45 (54.88–62.02)
Queensland 65.14 (60.54–69.75) 1.22 (0.75–1.70) 66.36 (61.75–70.98)
South Australia 62.87 (56.56–69.19) 1.25 (0.42–2.08) 64.12 (57.84–70.39)
Western Australia 68.75 (62.37–75.12) 1.14 (0.45–1.83) 69.88 (63.41–76.35)
Tasmania 68.07 (57.16–78.98) 1.78 (0.18–3.37) 69.84 (58.95–80.72)
Northern Territory 87.33 (54.07–120.58) 2.13 (0.00–5.01) 89.45 (56.71–122.19)
Rurality† (missing data for 2199 consultations*)
Major cities 59.48 (57.31–61.65) 1.16 (0.91–1.41) 60.63 (58.44–62.83)
Inner regional 61.16 (57.21–65.12) 0.94 (0.50–1.37) 62.09 (58.07–66.12)
Outer regional 63.70 (56.75–70.65) 1.07 (0.42–1.72) 64.76 (57.71–71.81)
Remote 56.36 (41.0–71.72) 1.52 (0.00–3.55) 57.88 (42.01–73.75)
Very remote 64.40 (38.06–90.74) 1.79 (0.00–5.21) 66.18 (39.91–92.46)
* Missing data removed from denominator. † Defined by Australian Standard Geographical Classification groups. ◆111MJA 197 (2) · 16 July 2012
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* Includes all prescribed
Dohme (Australia), Sydmanagement of emergency contracep-
tion than general contraception (Box
4). The most frequent procedural treat-
ments for general contraception were
related to fitting or removing of a con-
traceptive device. Women aged 35–54
years had more procedural treatments
in the management of their general
contraception because of a significantly
higher rate of local injection (for
administration of medroxyprogester-
one). Procedures were significantly
fewer for emergency contraception
problems, most being pregnancy tests
and Pap smears. Women aged 35–54
years were referred for general contra-
ceptive problems more often than 12–
24-year-olds, with most referred to
obstetricians and gynaecologists.
There were no referrals recorded for
emergency contraception problems.
Only 5.9 pathology tests were ordered
per 100 general contraception prob-
lems compared with 86.6 tests per 100
2   Rate of contraceptive management at 114 034 consultations with women aged 12–54 years according to general practitioner 
characteristics
Rate per 1000 consultations (95% CI)
General practitioner characteristic General contraception Emergency contraception Total contraception
Age (missing data for 604 consultations*)
< 35 years 75.07 (68.02–82.12) 1.22 (0.45–1.99) 76.30 (69.19–83.41)
35–44 years 62.71 (58.41–67.00) 1.16 (0.73–1.60) 63.87 (59.55–68.19)
45–54 years 61.46 (58.50–64.43) 1.33 (0.94–1.72) 62.80 (59.78–65.82)
 55 years 53.67 (50.72–56.63) 0.80 (0.51–1.10) 54.48 (51.52–57.45)
Sex (no missing data)
Male 49.71 (47.56–51.86) 0.94 (0.68–1.199) 50.65 (48.48–52.83)
Female 70.32 (67.47–73.17) 1.27 (0.95–1.60) 71.60 (68.72–74.47)
FRACGP status (missing data for 505 consultations*)
Yes 63.43 (60.77–66.09) 1.22 (0.91–1.53) 64.66 (61.98–67.34)
No 56.76 (54.25–59.27) 0.99 (0.71–1.27) 57.76 (55.22–60.30)
Practice size† (missing data for 635 consultations*)
1 General practitioner 46.82 (38.33–55.32) 0.88 (0.02–1.75) 47.71 (39.11–56.30)
2–4 General practitioners 55.50 (51.05–59.94) 0.68 (0.28–1.08) 56.18 (51.70–60.65)
5–9 General practitioners 65.11 (61.08–69.14) 1.10 (0.65–1.54) 66.21 (62.14–70.29)
10–14 General practitioners 60.48 (53.96–66.99) 1.87 (0.98–2.76) 62.35 (55.73–68.97)
 15 General practitioners 65.02 (56.28–73.77) 0.72 (0.00–1.53) 65.75 (57.07–74.42)
Country of graduation (missing data for 205 consultations*)
Australia 61.05 (58.84–63.27) 1.02 (0.78–1.25) 62.08 (59.84–64.317)
Overseas 58.01 (54.74–61.29 1.34 (0.91–1.77) 59.36 (56.05–62.67)
FRACGP = Fellow of the Royal Australian College of General Practitioners.
* Missing data removed from denominator. † Collected for the 2009–2011 data period, which included 56 873 consultations. ◆
ptive medication recorded by age group, 2007 to 2011
Rate per 100 contraception problems managed (95% CI)
General contraception Emergency contraception
Age group All ages All ages
12–24 years 25–34 years 34–44 years 45–54 years 12–54 years 12–54 years
ceptive pill* 78.1 (76.4–79.8) 66.3 (64.2–68.5) 58.0 (55.2–60.8) 58.4 (53.8–63.0) 68.6 (67.3–70.0) 7.1 (2.6–11.6)
nyloestradiol 42.8 (40.9–44.8) 36.7 (34.7–38.8) 41.3 (38.7–43.9) 43.5 (38.9–48.1) 40.5 (39.2–41.8) 3.1 (0.1–6.2)
yloestradiol 16.1 (14.6–17.6) 13.3 (11.8–14.8) 7.1 (5.7–8.4) 4.6 (2.7–6.5) 12.5 (11.6–13.4) 2.4 (0.0–5.0)
loestradiol 13.5 (12.2–14.9) 10.2 (9.0–11.5) 4.1 (3.0–5.1) 3.6 (1.9–5.2) 9.8 (9.0–10.5) 0.8 (0.0–2.3)
inyloestradiol 3.8 (3.1–4.5) 3.9 (3.1–4.7) 3.1 (2.2–4.1) 4.2 (2.3–6.1) 3.7 (3.3–4.2) 0
 contraception 11.8 (10.5–13.1) 15.4 (13.8–17.0) 20.3 (18.2–22.5) 20.8 (17.2–24.4) 15.4 (14.5–16.4) 0.8 (0.0–2.3)
ne† 6.1 (5.2–7.1) 8.6 (7.4–9.8) 11.6 (9.9–13.3) 13.0 (9.9–16.1) 8.6 (7.9–9.3) 0
5.3 (4.4–6.3) 4.8 (3.8–5.7) 4.8 (3.7–6.0) 3.2 (1.6–4.7) 4.9 (4.3–5.5) 0.8 (0.0–2.3)
uterine device 0.3 (0.1–0.6) 1.9 (1.3–2.5) 3.7 (2.6–4.8) 4.6 (2.8–6.5) 1.9 (1.4–2.3) 0
 device 0.0 (0.0–0.1) 0.1 (0.0–0.3) 0.2 (0.0–0.4) 0 0.1 (0.0–0.2) 0
4.1 (3.3–4.9) 7.3 (6.2–8.4) 7.2 (5.8–8.6) 5.3 (3.2–7.3) 5.9 (5.3–6.5) 48.0 (38.0–58.0)
1.2 (0.8–1.6) 3.9 (3.1–4.8) 3.8 (2.8–4.8) 2.5 (1.1–3.9) 2.7 (2.3–3.1) 43.3 (34.0–52.6)
onogestrel device§ 1.2 (0.7–1.6) 1.3 (0.8–1.8) 1.4 (0.8–2.0) 0 1.2 (0.9–1.5) 0
94.0 (92.9–95.2) 89.0 (87.5–90.5) 85.5 (83.4–87.6) 84.5 (81.1–87.8) 89.9 (89.0–90.9) 55.9 (45.4–66.4)
 combined oral contraceptive pills. † Depo-Provera, Pfizer Australia, Sydney, NSW. ‡ Implanon, Schering Plough, Sydney, NSW. § NuvaRing, Merck Sharp & 
















d pregnancy tests sent 
◆
emergency contraception problems;
most of these were tests for sexually
transmitted infections (STIs).
Discussion
This study on current contraceptive
management by GPs in Australia pro-
vides important insights into the high
rates of unplanned pregnancy that
exist despite patients reporting high
rates of contraceptive use.
Patient factors such as age, ethni-
city, Indigenous status and holding a
Commonwealth Health Care Card
were associated with lower rates of
contraceptive consultations. Rates of
management of general contracep-
tion and emergency contraception
were highest among young women
(18–24 years), and declined with
womens’ age. This could be because
older women are more likely to use
contraceptive methods that do not
require them to regularly fill pre-
scriptions (unlike younger women
who tend to rely most commonly on
COCPs). However, these lower rates
of encounter may also account for
the increasing levels of unplanned
pregnancy and abortion being seen
in women in this age group.15,16
Women who spoke a language
other than English at home had a rate
of management of general contracep-
tion that was half that of women from
E n gl i sh -speakin g ho us eho lds .
Local3,17 and international18,19 data
show that ethnicity influences the
type of contraception used. The popu-
larity of the COCP is lower among
women of non-English-speaking
background than loca lly  born
women.6,18-20
Supporting previous Australian
studies,1,5,6,17 we found high use of
the COCP, moderate use of LARC
(especially among 34–54 year olds),
and low rates of management of
emergency contraception. This proba-
bly reflects age and life-stage appro-
priateness of the agents being
prescribed.21 The COCP has been
found to be the preferred method of
contraception before and between
pregnancies, but its rate of use
decreases with age and with higher
numbers of pregnancies.5,22 Middle-
aged women tend to use longer-term
methods of contraception when no
further pregnancies are desirable,5
and this strategy requires fewer visits
to GPs.
GPs’ views influence the advice
they give to potential users, the avail-
ability of particular contraceptive
methods and the type of contracep-
tion selected by patients.3 Lack of
familiarity among GPs with inserting
and removing intrauterine devices
(IUDs) and implants resulting from a
lack of appropriate technical training
and from medical indemnity insur-
ance costs may be factors exacerbat-
ing difficulties women have in
o b ta in i n g  i n f o rm a t i on  a bo u t
LARCs.23-25 Women are also poorly
advised or have misconceptions that
IUDs are unsuitable, even when they
meet the medical eligibility criteria.17
However, the gradual rise in the use
of implants among younger women,
suggests a possible trend towards
LARC.22
Young women (aged 18–24 years)
had the highest rate of management
of emergency contraception, but over-
all rates of management of emergency
contraception in general practice is
low. This may be because women can
obtain emergency contraception over-
the-counter, or because GPs are not
integrating this form of contraception,
including advance prescription of
emergency contraception, into con-
sultations involving sexual and repro-
ductive health. Many women who
received emergency contraception
from GPs in our study, also received
counselling and tests for STIs. The
value of these additional services
should be weighed against increased
accessibility though over-the-counter
purchase.
Women’s preference to see female
GPs for matters related to reproduc-
tion and contraception is well-estab-
lished.26-28 Other GP characteristics
4   Non-pharmacological management of contraception problems by age group
Rate per 100 contraceptive problems managed (95% CI)
General contraceptive Em
Age group All ages
Clinical treatment 12–24 years 25–34 years 35–44 years 45–54 years 12–54 years
Counselling/advice/education 24.3 (22.2–26.4) 17.3 (15.5–19.2) 15.9 (13.9–18.0) 14.9 (11.3–18.5) 19.6 (18.3–20.9)
Procedures 
Hormone implant 5.2 (4.3–6.2) 5.1 (4.0–6.1) 6.4 (4.9–7.8) 5.0 (2.8–7.3) 5.4  (4.7–6.1)
Local injection* 3.4 (2.7–4.2) 5.0 (4.1–6.0) 6.6 (5.2–8.0) 8.0 (5.6–10.4) 4.9 (4.4–5.5)
Contraceptive device fitting/supply/removal 0.4 (0.2–0.7) 1.7 (1.1–2.4) 2.0 (1.3–2.8) 3.4 (1.6–5.2) 1.4 (1.0–1.7)
Pap smear 1.1 (0.7–1.6) 1.6 (1.1–2.1) 0.8 (0.4–1.3) 1.1 (0.1–2.0) 1.2  (0.9–1.5)
Pregnancy test 0.5 (0.2–0.8) 0.8 (0.4–1.1) 0.6 (0.2–0.9) 0.2 (0–0.6) 0.6 (0.4–0.8)
Total procedures 11.4 (10.0–12.8) 15.3 (13.6–17.0) 17.5 (15.2–19.7) 18.3 (14.6–21.9) 14.4 (13.4–15.5)
Referrals
Obstetrician/gynaecologist 0.3 (0.1–0.5) 1.7 (1.1–2.2) 4.1 (3.1–5.2) 4.4 (2.6–6.3) 1.8 (1.5–2.2)
Total referrals 0.7 (0.4–1.1) 2.1 (1.6–2.7) 5.7 (4.5–7.0) 5.5 (3.4–7.5) 2.6 (2.2–3.0)
Pathology tests
STI tests† 1.5 (0.9–2.1) 0.5 (0.2–0.9) 0.3 (0–0.7) 0.4 (0–1.0) 0.9 (0.6–1.1)
Total pathology tests‡ 5.2 (3.9–6.4) 6.4 (4.9–8.0) 5.5 (3.6–7.5) 8.0 (2.9–13.1) 5.9 (4.9–6.8)
STI = sexually transmitted infection.
* Includes Depo-Provera (Pfizer Australia, Sydney, NSW). † Includes STI screen, hepatitis serological testing, HIV and Chlamydia tests. ‡ Includes Pap smears, an
to pathology laboratories.113MJA 197 (2) · 16 July 2012
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traceptive management, such as
younger age and holding an RACGP
Fellowship, may reflect outcomes of
better training in these graduates.
The lower rates of counselling and
advice provided in managing general
contraception compared with emer-
gency contraception may reflect the
need for regular visits for repeat pre-
scriptions, and that GPs may have
provided advice and counselling in
earlier consultations but opportunities
to improve health literacy in sexual
and reproductive health may be being
missed.
The statistical reliability and validity
of BEACH has been established29 and
results from this study are rigorous.
Nevertheless it has limitations; more
frequent visits to GPs to obtain COCP
prescriptions compared with a single
visit for emergency contraception
means that our study sample auto-
matically detected more cases of
COCP than emergency contraception.
A similar limitation applies to com-
paring COCP use with LARC.
Further research is needed into
GPs’ use of consultations with
women to manage contraception,
(particularly emergency contracep-
tion), to undertake related health
activities (eg, Pap smears and STI
tests). Qualitative work examining
patient and GP perspectives on con-
traception will yield better insight on
how to facilitate a shift to more effica-
cious long-term contraceptives.
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